36 - Services financiers, assurances et affaires immobilières
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Administration coordination and assistance services in the
nature of facilitating administrative coordination between
patients, health care facilities, pharmacies, and insurance
plans; providing information relating to collecting and
reporting pharmacy management and drug dispensing
information; providing pharmaceutical business information
in the nature of payer and provider information,
distribution tracking, formulary coverage; administering
pharmacy reimbursement programs and services. Financial and administrative services in the field of health
care, namely, financial consultation; providing insurance
information relating to insurance or insurance services;
insurance coverage monitoring services, namely, providing
status updates regarding requests for insurance coverage of
a pharmaceutical product; pharmacy benefit management
services; pharmacy benefit and claims processing management
services. Software as a service (SaaS) services featuring software for
electronically communicating information between patients,
medical professionals, health plans and health insurers, and
pharmacies in real-time; providing temporary use of online
non-downloadable computer software for the exchange of
information concerning prescriptions for pharmaceutical
drugs and insurance coverage; software as a service (SaaS)
services featuring software for insurance coverage
monitoring, namely, providing online status updates
regarding requests for insurance coverage of a
pharmaceutical product; providing temporary use of on-line
non-downloadable software via a centralized web-based
patient portal to permit the secure access of patient
pharmaceutical prescription and insurance information and to
access, maintain, manage and distribute patient
pharmaceutical prescription and insurance information, and
to facilitate communications, connectivity and workflow with
health care providers, health plans and health insurers, and
patients; providing temporary use of non-downloadable
computer software for use by pharmacy benefit managers,
health plans and health insurers, to perform health care
prior authorizations for health care services and
prescription drugs; software as a service (SaaS) services
featuring software for submitting and obtaining patient
information electronically into an electronic patient portal
platform and submit patient prescriptions electronically
through an e-prescribing portal; software as a service
(SaaS) featuring software for data processing systems for
pharmacies, namely, software for prescription processing,
prescription fulfillment, workflow management, prescription
insurance claim processing; software as a service (SaaS)
services featuring software for cost management in the field
of pharmaceuticals; platform as a service (PaaS) featuring
computer software platforms for implementing an Internet
website portal that provides data to healthcare providers,
health plans and health insurers, pharmacies, and patients.
36 - Services financiers, assurances et affaires immobilières
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Business administration coordination and assistance services in the nature of facilitating administrative coordination between patients, health care facilities, pharmacies, and insurance plans; providing business information relating to collecting and reporting pharmacy management and drug dispensing information; providing pharmaceutical business information in the nature of payer and provider information, distribution tracking, formulary coverage; business administration of pharmacy reimbursement programs and services Financial and administrative services in the field of health care, namely, financial consultation; providing insurance information relating to insurance or insurance services; insurance coverage monitoring services, namely, providing status updates regarding requests for insurance coverage of a pharmaceutical product; pharmacy benefit management services; pharmacy benefit management services and pharmaceutical insurance claims processing Software as a service (SAAS) services featuring software for electronically communicating information between patients, medical professionals, health plans and health insurers, and pharmacies in real-time; Providing temporary use of online non-downloadable computer software for the exchange of information concerning prescriptions for pharmaceutical drugs and insurance coverage; Software as a service (SAAS) services featuring software for insurance coverage monitoring, namely, providing online status updates regarding requests for insurance coverage of a pharmaceutical product; Providing temporary use of on-line non-downloadable software via a centralized web-based patient portal to permit the secure access of patient pharmaceutical prescription and insurance information and to access, maintain, manage and distribute patient pharmaceutical prescription and insurance information, and to facilitate communications, connectivity and workflow with health care providers, health plans and health insurers, and patients; Providing temporary use of non-downloadable computer software for use by pharmacy benefit managers, health plans and health insurers, to perform health care prior authorizations for health care services and prescription drugs; Software as a service (SAAS) services featuring software for submitting and obtaining patient information electronically into an electronic patient portal platform and submit patient prescriptions electronically through an e-prescribing portal; Software as a service (SAAS) featuring software for data processing systems for pharmacies, namely, software for prescription processing, prescription fulfillment, workflow management, prescription insurance claim processing; Software as a Service (SAAS) services featuring software for cost management in the field of pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for implementing an internet website portal that provides data to healthcare providers, health plans and health insurers, pharmacies, and patients
max of tiopronin after oral administration of the solid pharmaceutical composition when administered as a 300 milligram dose. As such, it is possible for the solid pharmaceutical composition to be administered orally with or without food (e.g., in a fed or fasted state) while still achieving a desired maximum plasma concentration of the tiopronin in a delayed release formulation.
A sprayable emulsion is provided. The emulsion can be used in the treatment of various skin conditions. The emulsion includes a hydrofluoro-based propellant, an emulsification system, an oil phase, a water phase, and active agent particles. Further, the emulsification system includes at least one nonionic emulsifier. The emulsion has a viscosity ranging from about 500 centipoise to about 10,000 centipoise and a hydrophilic to lipophilic balance (HLB) value of from about 2 to about 12. The present inventors have found that by selectively controlling the nature of the emulsification system and the viscosity of the emulsion, the active agent particles resist settling such that a substantially homogeneous distribution of the active agent particles is maintained and can be evenly sprayed onto a surface without running once applied.
A61K 47/34 - Composés macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. polyesters, acides polyaminés, polysiloxanes, polyphosphazines, copolymères de polyalkylène glycol ou de poloxamères
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 47/24 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant des atomes autres que des atomes de carbone, d'hydrogène, d'oxygène, d'halogènes, d'azote ou de soufre, p. ex. cyclométhicone ou phospholipides
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
On-line retail store services featuring pharmaceutical goods and dietary and nutritional supplements; distributorship services in the field of pharmaceutical and dietary supplement products. Development of dietary supplement products.
28.
Sprayable composition containing zinc oxide and a fluoro-olefin propellant
A sprayable zinc oxide composition is provided. The sprayable zinc oxide composition can be used in the treatment of various skin conditions. The sprayable zinc oxide composition includes zinc oxide particles and a fluoro-olefin propellant. The present inventors have found that by selecting a propellant having a certain specific gravity, vapor pressure, and molecular weight, and by controlling the viscosity of the various components of the composition, the resulting zinc oxide composition resists settling such that a substantially homogeneous distribution of zinc oxide particles is maintained and can be evenly sprayed onto a surface without running once applied.
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 47/06 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 47/24 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant des atomes autres que des atomes de carbone, d'hydrogène, d'oxygène, d'halogènes, d'azote ou de soufre, p. ex. cyclométhicone ou phospholipides
29.
Stabilized, sprayable emulsion containing active agent particles
A sprayable emulsion is provided. The emulsion can be used in the treatment of various skin conditions. The emulsion includes a hydrofluoro-based propellant, an emulsification system, an oil phase, a water phase, and active agent particles. Further, the emulsification system includes at least one nonionic emulsifier. The emulsion has a viscosity ranging from about 500 centipoise to about 10,000 centipoise and a hydrophilic to lipophilic balance (HLB) value of from about 2 to about 12. The present inventors have found that by selectively controlling the nature of the emulsification system and the viscosity of the emulsion, the active agent particles resist settling such that a substantially homogeneous distribution of the active agent particles is maintained and can be evenly sprayed onto a surface without running once applied.
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 47/24 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant des atomes autres que des atomes de carbone, d'hydrogène, d'oxygène, d'halogènes, d'azote ou de soufre, p. ex. cyclométhicone ou phospholipides
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A spray delivery system including a sprayable active agent composition housed within a container is provided that can be used in the treatment of various skin conditions. The composition includes a hydrofluoro-based propellant, a carrier fluid, and active agent particles, and has a viscosity ranging from about 500 centipoise to about 10,000 centipoise. The container includes a dip tube; a valve assembly that includes a valve body, a stem comprising a stem orifice, and a vapor tap; and an actuator. The dip tube is coupled to the actuator by the valve assembly, and the actuator is depressed to dispense the emulsion. By selectively controlling the components and viscosity of the composition and the dimensions of the container components, the active agent particles resist settling so a substantially homogeneous distribution of the particles is maintained. Thus, the composition can be evenly dispensed from the container as a fine mist without clogging.
B65D 83/14 - Récipients pour distribuer des contenus liquides ou semi-liquides par pression interne de gaz, c.-à-d. réceptacles aérosols contenant un propulseur
A61K 47/24 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant des atomes autres que des atomes de carbone, d'hydrogène, d'oxygène, d'halogènes, d'azote ou de soufre, p. ex. cyclométhicone ou phospholipides
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
B65D 83/48 - Valves actionnées par levage, p. ex. actionnées en poussant
B05B 7/04 - Pistolets pulvérisateursAppareillages pour l'évacuation avec des dispositifs permettant le mélange de liquides ou d'autres matériaux fluides avant l'évacuation
31.
SPRAYABLE COMPOSITION CONTAINING ZINC OXIDE AND A FLUORO-OLEFIN PROPELLANT
A sprayable zinc oxide composition is provided. The sprayable zinc oxide composition can be used in the treatment of various skin conditions. The sprayable zinc oxide composition includes zinc oxide particles and a fluoro-olefin propellant. The present inventors have found that by selecting a propellant having a certain specific gravity, vapor pressure, and molecular weight, and by controlling the viscosity of the various components of the composition, the resulting zinc oxide composition resists settling such that a substantially homogeneous distribution of zinc oxide particles is maintained and can be evenly sprayed onto a surface without running once applied.
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
32.
STABILIZED, SPRAYABLE EMULSION CONTAINING ACTIVE AGENT PARTICLES
A sprayable emulsion is provided. The emulsion can be used in the treatment of various skin conditions. The emulsion includes a hydrofluoro-based propellant, an emulsification system, an oil phase, a water phase, and active agent particles. Further, the emulsification system includes at least one nonionic emulsifier. The emulsion has a viscosity ranging from about 500 centipoise to about 10,000 centipoise and a hydrophilic to lipophilic balance (HLB) value of from about 2 to about 12. The present inventors have found that by selectively controlling the nature of the emulsification system and the viscosity of the emulsion, the active agent particles resist settling such that a substantially homogeneous distribution of the active agent particles is maintained and can be evenly sprayed onto a surface without running once applied.
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
A spray delivery system including a sprayable active agent composition housed within a container is provided that can be used in the treatment of various skin conditions. The composition includes a hydrofluoro-based propellant, a carrier fluid, and active agent particles, and has a viscosity ranging from about 500 centipoise to about 10,000 centipoise. The container includes a dip tube; a valve assembly that includes a valve body, a stem comprising a stem orifice, and a vapor tap; and an actuator. The dip tube is coupled to the actuator by the valve assembly, and the actuator is depressed to dispense the emulsion. By selectively controlling the components and viscosity of the composition and the dimensions of the container components, the active agent particles resist settling so a substantially homogeneous distribution of the particles is maintained. Thus, the composition can be evenly dispensed from the container as a fine mist without clogging.
B65D 83/06 - Réceptacles ou paquets comportant des moyens particuliers pour distribuer leur contenu pour distribuer un matériau pulvérulent ou granulaire
B65D 83/14 - Récipients pour distribuer des contenus liquides ou semi-liquides par pression interne de gaz, c.-à-d. réceptacles aérosols contenant un propulseur
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
pharmaceutical preparations for use in treating allergic and dermatologic disorders, namely, a topically applied acne treatment; pharmaceutical ointment used for the prevention and treatment of rash; pharmaceutical preparations for use in the treatment and prevention of skin disorders; analgesic balm; sodium salt tablets for use in the treatment of low blood level sodium; prenatal multi-vitamins and multi-minerals; dietary supplements inclusive of calcium salt; dietary supplements consisting primarily of calcium fluoride; prophylactic drug preventing calcium absorption by the human body; preparation for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance; preparation for the treatment of secondary anemia; detoxicating agents for use as liver protective agents; drug inclusive of potassium citrate for treatment of kidney stones and the urinary tract system; surgical lubricating jelly
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
pharmaceutical preparations for use in treating allergic and dermatologic disorders, namely, a topically applied acne treatment; pharmaceutical ointment used for the prevention and treatment of rash; pharmaceutical preparations for use in the treatment and prevention of skin disorders; analgesic balm; prenatal multi-vitamins and multi-minerals
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
pharmaceutical preparations for use in treating allergic and dermatologic disorders, namely, a topically applied acne treatment; pharmaceutical ointment used for the prevention and treatment of rash; pharmaceutical preparations for use in the treatment and prevention of skin disorders; analgesic balm; prenatal multi-vitamins and multi-minerals
05 - Produits pharmaceutiques, vétérinaires et hygièniques
35 - Publicité; Affaires commerciales
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
[ Dietary supplements for boosting energy ] On-line retail store services featuring pharmaceutical goods and dietary and nutritional supplements; distributorship services in the field of pharmaceutical and dietary supplement products Development of pharmaceutical and dietary supplement products
05 - Produits pharmaceutiques, vétérinaires et hygièniques
35 - Publicité; Affaires commerciales
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
[ Dietary supplements for boosting energy ] On-line retail store services featuring pharmaceutical goods and dietary and nutritional supplements; distributorship services in the field of pharmaceutical and dietary supplement products Development of pharmaceutical and dietary supplement products
05 - Produits pharmaceutiques, vétérinaires et hygièniques
35 - Publicité; Affaires commerciales
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Pain relief medication; therapeutic multivitamin combinations [ ; dietary supplements for boosting energy ] On-line retail store services featuring pharmaceutical goods and dietary and nutritional supplements; distributorship services in the field of pharmaceutical and dietary supplement products Development of pharmaceutical and dietary supplement products
Compounds are provided herein which are coordination complexes of the formula, AxByCit2Fz•mH2O, wherein A is a cation selected from certain IA or IIA metal ions in the Periodic Table; B is a cation selected from certain IIA metal ions and certain divalent d-block transition metal ions; A and B are different; "Cit" is tribasic citric acid anion; the stoichiometric ratio of x to y is equal or higher than 1.0 but lower than 8.0; m is 0-12; and z is selected such that electroneutrality is preserved. Compounds provided herein are useful to treat dietary deficiencies, osteoporosis, osteopenia, bone loss, and risk of bone loss, as well as other medical conditions involving the need for administration of the various ions. In addition, the compounds can be used as fluoride sources for dental use and to fluoridate water systems.
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (USA)
Inventeur(s)
Schein, Catherine, H.
Chen, Deliang
Gilbertson, Scott, R.
Estrella-Jimenez, Maria
Gao, Jian
Walter, Mary, A.
Peterson, Johnny, W.
Abrégé
Small molecules and their derivatives are described for the treatment and/or prevention of intestinal fluid loss. Also disclosed are methods of using said molecules and their derivatives to treat and/or prevent conditions associated with increased levels of 3 ',5 '-adenosine monophosphate. Specific compositions of the invention are also novel.
A01N 35/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant deux liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. un radical aldéhyde
The present invention is directed to a novel short term slow release drug delivery system, preferably for solid oral dosage forms of water-soluble, alkaline salts of alkali metals and alkaline earth metals comprising polyvinylpyrrolidone and CPAA and preferably a wax component.
The present invention is directed to an enriched food product, such as a calcium- enriched chewable food product in which at least one piece of the food product provides the recommended daily DRI of elemental calcium. The enriched food product has a mouth feel, texture and taste substantially similar to a non-enriched food product. The food product may also provide Vitamin D3 in a range of 100-2400 IU and optionally may be enrobed with a flavored coating. The present invention is also directed to a method for producing the enriched food product.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
10 - Appareils et instruments médicaux
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Vitamins, minerals and dietary supplements; gels for use as a personal and surgical lubricant; pharmaceutical preparations for the treatment or prevention of osteoporosis, kidney and genito-urinary tract complications, cardiovascular complications, gastrointestinal complications, dental complications, anemia, pregnancy and lactation complications, cancer, electrolyte imbalance, myalgia, arthralgia, pain and fatigue; pharmaceutical products, namely, prophylactic drugs preventing calcium absorption by the human body, therapeutic multivitamin combinations, orally administered dietary supplements of calcium salt, orally administered dietary supplements of calcium salt with vitamin D, laxatives, analgesic preparations for internal use or topical application, antacid tablets for gastric hyperacidity, antispasmodic treatments, hematinic tablets of ferrous gluconate, therapeutic fluoride, folic acid tablets, preparations for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance, orally administered sodium salt tablets, high carbohydrate protein dietary food supplements, preparations for the treatment of secondary anemia, pharmaceutical preparations in chewable tablet dosage form, namely, antispasmodic, anticholinergics, antacids, antihistamines, antibiotics, antiasmatics and antinauscas, for dietary supplements as a magnesium and citrate inhibitor indicated as prophylactic for recurring kidney stones, for surgical lubricating jelly, vitamin and mineral preparations in liquid tablet and capsule form, slow-release salt tablets, prophylactic and treatment drug of potassium citrate embodied in slow-release wax matrix to prevent or dissolve kidney stones, orally administered potassium phosphate preparations utilized for treatment of kidney stones, pharmaceutical products prepared as an appetite depressant. Diagnostic test kits comprised primarily of a plastic collection container with chemically impregnated sponges and sample vials for use in kidney stone urinalysis; vacuum constriction devices for use in the treatment of impotency; vacuum constriction device for producing a penile erection-like state; medical apparatus for the diagnosis of kidney stones; urine collection kit consisting primarily of a plastic collection container with chemically impregnated sponge and sample vials for analyzing risk probabilities of developing kidney stones. Medical services, namely, providing diagnostic testing of urine samples for kidney stones.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceutical preparation that is a prophylactic and treatment drug of potassium citrate embodied in a slow-release wax matrix to prevent or dissolve kidney stones.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
10 - Appareils et instruments médicaux
Produits et services
(1) Pharmaceutical products, namely, prophylactic drugs preventing calcium absorption by the human body, therapeutic multivitamin combinations, orally administered dietary supplements of calcium salt, orally administered dietary supplements of calcium salt with vitamin D, laxatives, analgesic preparations for internal use or topical application, antacid tablets for gastric hyperacidity, hematinic tablets of ferrous gluconate, therapeutic fluoride, folic acid tablets, pharmaceutical preparations in tablet form for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance, orally administered sodium salt tablets, pharmaceutical preparations in tablet form for the treatment of secondary anemia, pharmaceutical preparations in chewable tablet dosage form, namely, antispasmodic, anticholinergics, antacids, antihistamines, antibiotics, antiasmatics and antinauseas, for dietary supplements as a magnesium and citrate inhibitor indicated as prophylactic for recurring kidney stones, for surgical lubricating jelly, vitamin and mineral preparations in liquid and capsule form, slow-release salt tablets, prophylactic and treatment drug of potassium citrate embodied in slow-release wax matrix to prevent or dissolve kidney stones, orally administered potassium phosphate preparations utilized for treatment of kidney stones.
(2) Vitamins, minerals and orally administered dietary supplements of calcium salt and calcium salt with Vitamin D; surgical lubricating jelly; pharmaceutical preparations in chewable dosage form, liquid effervescent, and tablet form for the treatment or prevention of osteoporosis, kidney and genito-urinary tract complications, cardiovascular complications, gastrointestinal complications, dental complications, anemia, pregnancy and lactation complications, cancer, electrolyte imbalance, myalgia and arthralgia; analgesic preparations for internal use or topical application for the treatment of pain and fatigue.
(3) Diagnostic test kits for medical use; medical devices, namely, vacuum constriction devices for facilitating and maintaining penile erection for assisting males who are impotent.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
10 - Appareils et instruments médicaux
Produits et services
Vitamins, minerals and dietary supplements; [ Diagnostic test kits comprised primarily of a plastic collection container with chemically impregnated sponges and sample vials for use in kidney stone urinalysis; ] Gels for use as a personal and surgical lubricant; Pharmaceutical preparations for the treatment or prevention of osteoporosis, kidney and genito-urinary tract complications, cardiovascular complications, gastrointestinal complications, dental complications, anemia, pregnancy and lactation complications, cancer, electrolyte imbalance, myalgia, arthralgia, pain and fatigue [ Vacuum constriction devices for use in the treatment of impotency ]
05 - Produits pharmaceutiques, vétérinaires et hygièniques
10 - Appareils et instruments médicaux
Produits et services
Vitamins, minerals and dietary supplements; [ Diagnostic test kits comprised primarily of a plastic collection container with chemically impregnated sponges and sample vials for use in kidney stone urinalysis;] Gels for use as a personal and surgical lubricant; Pharmaceutical preparations for the treatment or prevention of osteoporosis, kidney and genito-urinary tract complications, cardiovascular complications, gastrointestinal complications, dental complications, anemia, pregnancy and lactation complications, cancer, electrolyte imbalance, myalgia, arthralgia, pain and fatigue [ Vacuum constriction devices for use in the treatment of impotency ]
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Vitamins, minerals and dietary supplements; diagnostic test kits for medical use; lubricants; devices for treatment of impotency; pharmaceutical preparations for the treatment or prevention of osteoporosis, kidney and genito-urinary tract complications, cardiovascular complications, gastrointestinal complications, dental complications, anaemia, pregnancy and lactation complications, cancer, electrolyte imbalance, myalgia, arthralgia, pain, and fatigue.
urine collection kit consisting primarily of a plastic collection container with chemically impregnated sponge and sample vials for analyzing risk probabilities of developing kidney stones
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
pharmaceutical products, namely, prophylactic drugs preventing calcium absorption by the human body, therapeutic multivitamin combinations, orally administered dietary supplements of calcium salt, orally administered dietary supplements of calcium salt with vitamin D, laxatives, analgesic preparations for internal use or topical application, antacid tablets for gastric hyperacidity, antispasmodic treatments, hematinic tablets of ferrous gluconate, therapeutic flouride, folic acid tablets, preparations for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance, orally administered sodium salt tablets, high carbohydrate protein dietary food supplements, preparations for the treatment of secondary anemia, pharmaceutical preparations in chewable tablet dosage form, namely, antispasmodic, anticholinergics, antacids, antihistamines, antibiotics, antiasmatics and antinauseas, for dietary supplements as a magnesium and citrate inhibitor indicated as prophylactic for recurring kidney stones, for surgical lubricating jelly, vitamin and mineral preparations in liquid tablet and capsule form, slow-release salt tablets, prophylactic and treatment drug of potassium citrate embodied in slow-release wax matrix to prevent or dissolve kidney stones, orally administered potassium phosphate preparations utilized for treatment of kidney stones, pharmacuetical products prepared as an appetite depressant
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
[PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR THE CARE OF THE LIVER AND TREATMENT OF LIVER DISORDERS; PREPARATIONS FOR THE CARE OF EPIDERMIC DISORDERS AND FOR RADIATION PROTECTION;] PREPARATIONS FOR [THE CARE OF CATARACT AND FOR] CYSTINURIA TREATMENT [; TREATMENT PREPARATIONS FOR HYPERTENSION; PREPARATIONS FOR BRONCHITIS TREATMENT AND EXPECTORANTS; AND PREPARATIONS FOR IMMUNOMODULATER]
